Jag Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.56M Sell
41,257
-560
-1% -$46.6K 0.33% 43
2026
Q2
$2.82M Buy
+41,817
New +$2.79M 0.26% 56
2023
Q4
– Sell
-17,835
Closed -$1.66M – 156
2023
Q3
$1.66M Sell
17,835
-61,236
-77% -$6.9M 0.2% 83
2023
Q2
$10.2M Sell
79,071
-830
-1% -$100K 1.17% 29
2023
Q1
$9.28M Sell
79,901
-51
-0.1% -$5.71K 1.2% 28
2022
Q4
$9.05M Buy
+79,952
New +$8.78M 1.31% 27

Other funds holding DXCM

Jag Capital Management's DXCM Position: Q3 2026 in Review

Jag Capital Management reduced its DexCom (DXCM) stake by 1.3% in Q3 2026, selling an estimated $46.6K and leaving 41,257 shares worth $3.56M. The position accounts for 0.33% of the portfolio, ranked #43.

Jag Capital Management first reported a position in DXCM in Q4 2022 and has held it in 6 quarters since. The position peaked at $10.2M in Q2 2023. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Jag Capital Management held 41,257 shares of DexCom worth $3.56M as of Q3 2026.
  • Jag Capital Management sold 560 DexCom shares in Q3 2026, an estimated $46.6K.
  • DexCom made up 0.33% of Jag Capital Management's portfolio in Q3 2026, its #43 holding.
  • Jag Capital Management first reported a position in DexCom in Q4 2022 and has held it in 6 quarters since.
  • Jag Capital Management's DexCom position peaked at $10.2M in Q2 2023.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Jag Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.